Translational Development Acquisition Corp. Ordinary Shares Cash Flow Quality Index
Translational Development Acquisition Corp. Ordinary Shares cash flow quality index. Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Cash Flow Quality Index of -0.36x as of June 2026. Operating cash flow of $-338.75K is below net income of $946.98K, suggesting accrual-heavy earnings not yet converted to cash. See Translational Development Acquisition Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Translational Development Acquisition Corp. Ordinary Shares (2025–2025)
Cash flow quality index of Translational Development Acquisition Corp. Ordinary Shares from 2025 to 2025. Historical Cash Flow Quality Index for Translational Development Acquisition Corp. Ordinary Shares across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Translational Development Acquisition Co (TDAC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Translational Development Acquisition Corp. Ordinary Shares Cash Flow Quality Index by Year (2025–2025)
Translational Development Acquisition Corp. Ordinary Shares cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Translational Development Acquisition Corp. Ordinary Shares. For the full cash flow conversion analysis, see cash flow conversion of Translational Development Acquisition Co.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | $-608.39K | $6.36 Million | — |